Researchers are developing a live-attenuated Zika vaccine candidate, with some studies focusing on its effectiveness in non-human primates and mice. The vaccine candidate has been modified, including a change to its 5′ untranslated region, in an effort to create a safe and effective vaccine. Various approaches to developing a Zika vaccine are being explored, including the use of synthetic biology and virus vectoring.